Sivik Global Healthcare’s Perrigo PRGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-65,000
Closed -$4.95M 58
2020
Q1
$4.95M Buy
+65,000
New +$3.49M 1.95% 24
2019
Q2
Sell
-40,000
Closed -$1.93M 67
2019
Q1
$1.93M Buy
+40,000
New +$1.87M 0.71% 50
2017
Q4
Sell
-25,000
Closed -$2.12M 78
2017
Q3
$2.12M Sell
25,000
-20,000
-44% -$1.56M 0.72% 52
2017
Q2
$3.4M Buy
45,000
+20,000
+80% +$1.43M 1.24% 33
2017
Q1
$1.66M Buy
+25,000
New +$1.9M 0.77% 46
2015
Q4
Sell
-15,000
Closed -$2.36M 65
2015
Q3
$2.36M Hold
15,000
1.14% 34
2015
Q2
$2.77M Sell
15,000
-15,000
-50% -$2.86M 0.96% 42
2015
Q1
$4.97M Buy
30,000
+10,200
+52% +$1.63M 1.69% 22
2014
Q4
$3.31M Buy
+19,800
New +$3.1M 1.34% 34
2014
Q3
Sell
-10,000
Closed -$1.46M 78
2014
Q2
$1.46M Buy
+10,000
New +$1.42M 0.74% 54

Other funds holding PRGO

Sivik Global Healthcare's PRGO Position: Q2 2020 in Review

Sivik Global Healthcare sold out of Perrigo (PRGO) in Q2 2020, closing a stake of 65,000 shares — an estimated $4.95M sold.

Sivik Global Healthcare first reported a position in PRGO in Q2 2014 and held it in 10 quarters. The position peaked at $4.97M in Q1 2015. 351 funds tracked by Wall St. Rank hold PRGO as of Q2 2020.

  • Sivik Global Healthcare reported no remaining Perrigo position as of Q2 2020 after selling out during the quarter.
  • Sivik Global Healthcare sold 65,000 Perrigo shares in Q2 2020, an estimated $4.95M.
  • Sivik Global Healthcare first reported a position in Perrigo in Q2 2014 and held it in 10 quarters.
  • Sivik Global Healthcare's Perrigo position peaked at $4.97M in Q1 2015.
  • 351 funds tracked by Wall St. Rank held Perrigo as of Q2 2020.

Based on Sivik Global Healthcare's 13F filing for Q2 2020, filed 14 Aug 2020.